NON-INVASIVE BRAIN STIMULATION IN PSYCHIATRY: THE CASE OF TMS

By 24 Giugno 2022

Opzioni

Inizia tra 1 Mese, 5 Giorni

22 Settembre 2022

Typology: LEE (Live Educational Event – Course)
Event Dates: September 22nd, 23rd 2022
City: Rome, Italy
Venue: Hotel Barceló Aran Mantegna, Via Andrea Mantegna 130, 00147
Target audience:  Psychiatric specialists
Official language: English

 

Event agenda: read
Scientific Director: Prof. Stefano Pallanti
Faculty’s COI: read

 

An application has been made to the UEMS EACCME for CME accreditation of this event

 

SCIENTIFIC RATIONALE

Non-invasive brain stimulation (NIBS) techniques represent widely used physical therapies in neurology and psychiatry. Among the most widely adopted are those based on the use of magnetic fields (TMS, Transcranial Magnetic Stimulation) or electromagnetic fields (tDCS, transcranial Direct Current Stimulation) applied to the scalp. In both cases, brain activity is modulated in discrete areas below the site of delivery through activation or inhibition of the excitability threshold or neuronal discharge.

 

Both TMS and tDCS have few contraindications, few side effects and validated efficacy across a wide range of disorders (depression, OCD, chronic pain, Parkinson’s disease, motor stroke, addiction, etc.): for these disorders the efficacy level is very high (level A) and where this is not reached there are still measures of approvals from regulatory bodies (FDA, NICE, etc.). For depression and OCD, TMS therapy is approved for drug-resistant disorders, but this does not mean that TMS is an alternative to pharmacological treatment; if anything, in many cases it represents an excellent support to improve the outcomes in combination with pharmacological therapy. Regarding schizophrenia, the most recent international guidelines identify NIBS with different levels of efficacy on the negative symptoms and auditory hallucinations present in this disorder: in particular, the level of recommendation is C for TMS (probable efficacy) and B for tDCS (possible efficacy).

 

As such, guidelines take a long time to be published, and therefore refer to studies conducted in the years prior to their publication or revision. However, the most recent publications confirm the efficacy of these techniques while also supporting the favourable association with concomitant pharmacological treatments. Both technologies involve a series of therapeutic sessions, the number and frequency of which depend on the protocols applied, but while TMS treatments are outpatient, for tDCS, remotely controlled systems allowing home treatment are available.

 

EXPECTED LEARNING OUTCOMES

After attending the event participants will be able to:

– analyse and evaluate the latest evidence, guidelines and protocols on NIBS techiniques, particularly TMS for the treatment of conditions like schizophrenia, depression, OCD, chronic pain, Parkison’s disease, motor stroke, addiction;

– manage advanced skills on the use of NIBS techniques, particularly the TMS terapy, in the treatment of a wide range of disorders (schizophrenia, depression, OCD, chronic pain, Parkison’s disease, motor stroke, addiction);

– develop and apply an interdisciplinary clinical approach to the treatment of conditions like schizophrenia, depression, OCD, chronic pain, Parkinson’s desease, motor stroke, addiction, using non-invasive brain stimulation techniques, particularly TMS terapy, with concomitant pharmacological treatments.

PROVIDER ECM 
ID 5452
LETSCOME3 S.r.l.
Via Grazia Deledda 75/81 – 00137 Roma
Telefono +39 06 91502790

www.letscome3.it


REGISTRATIONS

    Consenso al trattamento dei dati personali

    Il sottoscritto dichiara di aver ricevuto completa informativa ai sensi dell'art. 13 del Regolamento UE 2016/679 ed esprime il consenso al trattamento ed alla comunicazione dei propri dati personali nei limiti, per le finalità e per la durata precisati nell'informativa. L'eventuale rifiuto nel consentire il trattamento dei dati comporta l'impossibilità di usufruire del servizio richiesto dall'utente.


    Consent for personal data processing
    The undersigned declares that he/she has received full consent pursuant to Art. 13 of EU Regulation 2016/679 and expresses his/her consent to the processing and communication of his/her personal data within the limits, for the purposes and for the duration specified in the information notice. Any refusal to consent to the processing of data will make it impossible to use the service requested by the user.



    With an unrestricted educational grant from:

    RECORDATI SPA
    ATID SRL
    GEA SOLUZIONI SRL